|
News For CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ From The Last 14 Days Check below for free stories on CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ the last two weeks. |
|
|
| May 7, 2013 |
| 08:57 EDT |  | AET | Aetna completes acquisition of Coventry Health
Aetna announced it has completed its acquisition of Coventry Health Care, a diversified managed health care company based in Bethesda, Md. "The successful completion of our acquisition of Coventry presents new opportunities for Aetna and supports our strategy for growth in the changing health care marketplace," said the company. "Together, we are well positioned - competitively, strategically and financially - to meet the evolving needs of the people we serve." |
|
| May 6, 2013 |
| 12:53 EDT |  | AET, CVH | On The Fly: Midday Wrap
 Subscribe for More Information |
|
| 10:04 EDT |  | UNH | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 10:04 EDT |  | HUM | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 09:19 EDT | | MDT | Medtronic receives FDA approval for newest cardiac devices
Medtronic announced FDA approval and U.S. launch of its newest cardiac devices: the Viva portfolio of cardiac resynchronization therapy with defibrillation, or CRT-D, devices, and the Evera portfolio of implantable cardioverter-defibrillators. |
|
| 08:06 EDT | | BSX | Boston Scientific completes first-in-human clinical trial of IntellaTip Mifi XP
Boston Scientific completed a first-in-human clinical trial utilizing the IntellaTip MiFi XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia originating in the right atrium of the heart that affects nearly one million people in the United States. This single center feasibility trial enrolled 10 patients and was led by Prash Sanders, MBBS, PhD, FHRS, director of the Centre for Heart Rhythm Disorders at the University of Adelaide and the Royal Adelaide Hospital. Patients with type 1 atrial flutter may exhibit symptoms that include palpitations, shortness of breath, fatigue, lightheadedness and fainting. Catheter ablation, a procedure in which localized electrical energy is delivered into the heart tissue aimed at restoring the continuous normal rhythm, has become a first-line treatment approach for patients with recurrent type 1 atrial flutter and demonstrates more successful short- and long-term outcomes compared to anti-arrhythmic drug therapy. |
|
| 07:59 EDT | | UNH | UnitedHealth reinstated with an Overweight at JPMorgan
Target $70. |
|
| 07:58 EDT | | HUM | Humana upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information |
|
| 07:53 EDT |  | CI | Cigna management to meet with Deutsche Bank
Meeting to be held in New York on May 6 hosted by Deutsche Bank. |
|
| 06:53 EDT |  | CI, AET, CNC, WLP, CVH, WCG, AGP, HNT, UNH, HUM, HS, MOH | Health insurers plan to push Obamacare, Politico says
Subscribe for More Information |
| |
|
|
|
|
